Sembol | Vade sonu getirisi % | Hacim | Fiyat % | Kupon % | Vade Tarihi | Ödenmemiş tutar | Nominal değer | Asgari brm tutarı | İhraççı |
---|---|---|---|---|---|---|---|---|---|
AA5QDALLERGAN FNDG 15/25 | 8,33% | 0 | 99,79% | 3,80% | 2025-03-15 | 130,22 M USD | 1.000,00 USD | 2.000,00 USD | Allergan Funding SCS |
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045 | 8,14% | 50 K | 74,10% | 4,75% | 2045-03-15 | 53,51 M USD | 1.000,00 USD | 2.000,00 USD | Allergan Funding SCS |
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042 | 7,72% | 24 K | 76,91% | 4,63% | 2042-10-01 | 67,49 M USD | 1.000,00 USD | 2.000,00 USD | Actavis, Inc. |
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044 | 7,69% | 15 K | 77,85% | 4,85% | 2044-06-15 | 65,23 M USD | 1.000,00 USD | 2.000,00 USD | Allergan Funding SCS |
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035 | 7,11% | 20 K | 84,96% | 4,55% | 2035-03-15 | 107,65 M USD | 1.000,00 USD | 2.000,00 USD | Allergan Funding SCS |
6,46% | 14,78 M | 99,87% | 3,80% | 2025-03-15 | 2,89 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,76% | 41,72 M | 84,57% | 4,25% | 2049-11-21 | 5,75 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,75% | 235 K | 90,14% | 4,63% | 2042-10-01 | 389,22 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,74% | 26 K | 90,47% | 3,20% | 2029-11-21 | 62,52 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,67% | 0 | 88,21% | 4,45% | 2046-05-14 | 2 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,61% | 0 | 91,36% | 4,70% | 2045-05-14 | 2,7 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,56% | 6,85 M | 89,69% | 4,40% | 2042-11-06 | 2,6 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,55% | 4,94 M | 93,08% | 4,88% | 2048-11-14 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,53% | 145 K | 92,55% | 4,75% | 2045-03-15 | 827,09 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,51% | 3,57 M | 88,16% | 4,05% | 2039-11-21 | 4 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,49% | 573 K | 100,08% | 5,50% | 2064-03-15 | 1,5 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,49% | 500 K | 94,02% | 4,85% | 2044-06-15 | 1,01 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,39% | 40,92 M | 100,08% | 5,40% | 2054-03-15 | 3 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,33% | 32,92 M | 103,17% | 5,60% | 2055-03-15 | 750 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,28% | 2,25 M | 100,62% | 5,35% | 2044-03-15 | 750 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,22% | 0 | 93,50% | 4,30% | 2036-05-14 | 1 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,11% | 0 | 95,91% | 4,50% | 2035-05-14 | 2,5 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
5,08% | 5,54 M | 96,50% | 4,55% | 2035-03-15 | 1,68 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
4,94% | 0 | 99,72% | 3,60% | 2025-05-14 | 3,75 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
4,94% | 21,01 M | 101,75% | 5,20% | 2035-03-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
4,93% | 22,7 M | 100,76% | 5,05% | 2034-03-15 | 3 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
4,72% | 27,25 M | 94,11% | 3,20% | 2029-11-21 | 5,44 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
4,65% | 9,48 M | 101,41% | 4,95% | 2031-03-15 | 2 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
4,63% | 23,62 M | 101,00% | 4,88% | 2030-03-15 | 1 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
4,57% | 2,75 M | 100,79% | 4,80% | 2029-03-15 | 2,5 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
4,47% | 10,72 M | 99,29% | 4,25% | 2028-11-14 | 1,75 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
4,46% | 20,49 M | 100,50% | 4,65% | 2028-03-15 | 1,25 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
4,42% | 0 | 98,60% | 3,20% | 2026-05-14 | 2 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
4,42% | 13,63 M | 97,63% | 2,95% | 2026-11-21 | 3,99 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
4,40% | 1,01 M | 100,75% | 4,80% | 2027-03-15 | 2,25 B USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
4,25% | 0 | 94,77% | 2,63% | 2028-11-15 | 72,11 M EUR | 1.000,00 EUR | 100.000,00 EUR | Allergan Funding SCS | |
XXS162262122ALLERGAN FNDG 17/29 | 3,87% | 0 | 93,63% | 2,13% | 2029-06-01 | 36,46 M EUR | 1.000,00 EUR | 100.000,00 EUR | Allergan Funding SCS |
3,86% | 0 | 96,53% | 2,95% | 2026-11-21 | 9,24 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
3,08% | 0 | 89,80% | 1,25% | 2031-11-18 | 650 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. | |
3,01% | 0 | 102,15% | 3,80% | 2025-03-15 | 1,27 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
2,90% | 0 | 121,31% | 4,25% | 2049-11-21 | 4,95 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
2,88% | 0 | 126,76% | 4,75% | 2045-03-15 | 5 K USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
2,83% | 0 | 128,71% | 4,85% | 2044-06-15 | 100 K USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
2,81% | 0 | 97,40% | 2,13% | 2029-06-01 | 506,09 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. | |
2,75% | 0 | 99,58% | 2,63% | 2028-11-15 | 427,79 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. | |
2,73% | 0 | 97,94% | 2,13% | 2028-11-17 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. | |
2,65% | 0 | 95,18% | 0,75% | 2027-11-18 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | AbbVie, Inc. | |
2,35% | 0 | 123,74% | 4,55% | 2035-03-15 | 1 K USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
— | — | — | 4,40% | 2042-11-06 | 1,1 M USD | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. | |
— | — | — | 3,80% | 2025-03-15 | — | 1.000,00 USD | 2.000,00 USD | AbbVie, Inc. |